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crucial role in the pathophysiology of postoperative ileus (POI). However, this
conclusion was mainly drawn using mast cell-deficient mouse models with abnormal
Kit signaling. These mice also lack interstitial cells of Cajal (ICC) resulting in aberrant
gastrointestinal motility even prior to surgery, compromising their use as model to study
POI. To avoid these experimental weaknesses we took advantage of a newly
developed knock-in mouse model, Cpa3Cre/+, devoid of mast cells but with intact Kit
signaling.
Design: The role of mast cells in the development of POI and intestinal inflammation
was evaluated assessing gastrointestinal transit and muscularis externa inflammation
after IM in two strains of mice lacking mast cells, i.e. KitW-sh/W-sh and Cpa3Cre/+
mice, and by use of the mast cell stabilizer cromolyn.
Results: KitW-sh/W-sh mice lack ICC networks and already revealed significantly
delayed gastrointestinal transit even before surgery. IM did not further delay intestinal
transit, but induced infiltration of myeloperoxidase positive cells, expression of
inflammatory cytokines and recruitment of monocytes and neutrophils into the
muscularis externa. On the contrary, Cpa3Cre/+ mice have a normal network of ICC
and normal gastrointestinal. Surprisingly, IM in Cpa3Cre/+ mice caused delay in gut
motility and intestinal inflammation as in wild type littermates mice (Cpa3+/+).
Furthermore, treatment with the mast cells inhibitor cromolyn resulted in an inhibition of
mast cells without preventing POI.
Conclusions: Here, we confirm that IM-induced mast cell degranulation. However, our
data demonstrate that mast cells are not required for the pathogenesis of POI in mice.
Although there might be species differences between mouse and human, our results
argue against mast cell inhibitors as a therapeutic approach to shorten POI.
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phenotype in Kit mutant mice leading to misleading experimental conclusion. A
detailed list of these cases is punctually reviewed in a recent perspective article
published in Immunity by Prof. Hans-Reimer Rodewald and Dr. Thorsten B.
Feyerabend (Widespread Immunological Functions of Mast Cells: Fact or Fiction?;
Immunity 37, 13-24 July 27, 2012). Based on our results, we feel that POI should be
added to this list.
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Abstract  
Introduction: Intestinal manipulation (IM) during abdominal surgery results in intestinal 
inflammation leading to hypomotility or ileus. Mast cell activation is thought to play a 
crucial role in the pathophysiology of postoperative ileus (POI). However, this 
conclusion was mainly drawn using mast cell-deficient mouse models with abnormal Kit 
signaling. These mice also lack interstitial cells of Cajal (ICC) resulting in aberrant 
gastrointestinal motility even prior to surgery, compromising their use as model to study 
POI. To avoid these experimental weaknesses we took advantage of a newly developed 
knock-in mouse model, Cpa3
Cre/+
, devoid of mast cells but with intact Kit signaling.  
Design: The role of mast cells in the development of POI and intestinal inflammation 
was evaluated assessing gastrointestinal transit and muscularis externa inflammation after 
IM in two strains of mice lacking mast cells, i.e. Kit
W-sh/W-sh
 and Cpa3
Cre/+
 mice, and by 
use of the mast cell stabilizer cromolyn. 
Results: Kit
W-sh/W-sh
 mice lack ICC networks and already revealed significantly delayed 
gastrointestinal transit even before surgery. IM did not further delay intestinal transit, but 
induced infiltration of myeloperoxidase positive cells, expression of inflammatory 
cytokines and recruitment of monocytes and neutrophils into the muscularis externa. On 
the contrary, Cpa3
Cre/+
 mice have a normal network of ICC and normal gastrointestinal. 
Surprisingly, IM in Cpa3
Cre/+
 mice caused delay in gut motility and intestinal 
inflammation as in wild type littermates mice (Cpa3
+/+
). Furthermore, treatment with the 
mast cells inhibitor cromolyn resulted in an inhibition of mast cells without preventing 
POI.  
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Conclusions: Here, we confirm that IM-induced mast cell degranulation. However, our 
data demonstrate that mast cells are not required for the pathogenesis of POI in mice.  
Although there might be species differences between mouse and human, our results argue 
against mast cell inhibitors as a therapeutic approach to shorten POI.    
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Introduction 
Open abdominal surgery leads to impaired motility of the entire gastrointestinal 
(GI) tract, a condition referred to as postoperative ileus (POI) [1]. Depending on the type 
of surgery, POI may last several days and, in up to 10% of patients, it might be prolonged 
to over 2 weeks, with symptoms including nausea, vomiting, intolerance to food and 
absence of defecation [2]. In addition to significant patient morbidity, POI is associated 
with increased hospital costs [3]. Therefore, any reduction in the occurrence or duration 
of POI could lead to a significant reduction in hospitalization and related costs.  
POI is an immune-mediated condition characterized by a localized inflammatory 
reaction in the muscularis externa evoked by intestinal handling during surgery [4]. 
Macrophages residing in the muscularis externa and mast cells have been proposed to be 
the key players in this inflammatory cascade [4]. Pharmacological or genetic (op/op 
mice) depletion of resident macrophages indeed results in a decrease of inflammatory 
mediators and diminished the recruitment of leucocytes into the muscularis supporting a 
role for intestinal macrophages in the induction of POI [5].  Activation of muscularis 
intestinal resident macrophages subsequently leads to cytokine and chemokine release, 
followed by an influx of leucocytes starting approximately 3–4 h after surgery [6]. 
Finally, incoming leucocytes in conjunction with muscularis macrophages (after surgery-
related-IM) induce the synthesis of prostaglandins and nitric oxide that directly impair 
smooth muscle contractility and consequently lead to POI [7,8].  
In addition to activation of muscularis macrophages after abdominal surgery, one 
of the earliest observations in rodents and humans is the activation of peritoneal mast 
cells with the release of their mediators into the peritoneal cavity [9] [10]. The 
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importance of mast cells in the inflammatory cascade triggered by IM was also suggested 
by experiments using mast cell stabilizers such as ketotifen and doxantrazole. The 
treatment with the above mentioned stabilizers reduced the inflammatory response and 
the delay in gastrointestinal transit 24 h after abdominal surgery. Moreover, mutant mice 
lacking mast cells (Kit
W/Wv
 and Kit
W-sh/W-sh
) showed reduced intestinal infiltrate following 
IM while reconstitution with wild type mast cells restored the phenotype [9,11]. 
However, the role of mast cells in POI is not free of criticism since the mediators 
measured (proteases and tryptases) can be released even by other immune cells, while the 
mast cell degranulation agonist (compound 48/80) and stabilizers (ketotifen and 
doxantrazole) used are not specific for mast cells.  In addition to the specificity of the 
compounds tested, the use of mast cells deficient mice based on Kit mutations is 
ambiguous, as the strains used (Kit
W/Wv
 and Kit
W-sh/W-sh
) have alterations in multiple cell 
types of both immune and non-immune origin in addition to the mast cell defect [12–17]. 
In particular, Kit is necessary for the development of interstitial cells of Cajal (ICC), with 
both Kit
W/Wv
 and Kit
W-sh/W-sh 
strains
 
having severe alteration of the ICC networks in the 
intestinal wall [15–17], and thus these mutations may cause mast cell-independent defects 
in gut motility.   
To avoid this experimental bias in the current study, we used a genetic modified 
mouse strain (Cpa3
Cre/+
) with a targeted insertion of Cre-recombinase into the 
Carboxypeptidase A3 (Cpa3) locus. This intervention leads to the specific mast cells 
ablation in tissues by a genotoxic transformation related protein 53 (Trp53)-dependent 
mechanism [18,19]. In contrast to Kit mutants, Cpa3
Cre/+
 mutants have a selective mast 
cell depletion and apart from a reduction in basophils numbers, other subpopulations of 
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immune cells are intact [18]. Therefore, this new transgenic mouse model gives us the 
opportunity to specifically evaluate the role of mast cells in POI.  
Here we show that Kit
W-sh/W-sh 
mice have impaired gut motility at baseline due to 
the alterations on ICC distribution, making this mouse strain unsuitable to study the role 
of mast cells in POI. By contrast, the selective depletion of mast cells (and partially of 
basophils) does not affect GI motility and does not prevent the development of IM-
induced muscular inflammation and POI. Taken together, our data indicate that mast cells 
are not crucial in the development of POI.  
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Material and Methods 
Animals 
Wild type mice (C57BL/6JOlaHsd) were purchased from Harlan. Kit
W-sh/W-sh 
mice 
were obtained by homozygote mating of mice originally purchased from The Jackson 
Laboratory [20]. Cpa3
Cre/+
 gene-targeted mice have been described previously [18,21]. 
Mice were kept at the KU Leuven animal facility under SPF conditions. All experimental 
procedures were approved by the Animal Care and Animal Experiments Committee of 
the Medical Faculty of the University of Leuven (Leuven, Belgium). 
Surgical procedure to induce postoperative ileus 
Mice were anesthetized by intraperitoneal injection (i.p.) of a mixture of 
Ketamine (Ketalar 100 mg/kg; Pfizer) and Xylazine (Rompun 10 mg/kg; Bayer). 
Anesthetized mice underwent a laparotomy alone or a laparotomy followed by IM [9,22–
24]. Surgery was performed using a sterile moist cotton applicator attached to a device 
enabling the application of a constant pressure of 90 mN [25]. The small intestine was 
manipulated three times from the caecum to the distal duodenum. During and after the 
surgical procedure, mice were positioned on a heating pad (32°C) until they recovered 
from anesthesia. No pharmacological treatment was used to avoid influence on the 
outcome of the study. 
Gastrointestinal transit measurements 
To assess GI transit, 10 µl of a liquid non-absorbable fluorescein isothiocyanate-
labeled dextran (FITC-dextran, 70,000 Da; Invitrogen) was administered intragastrically 
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24 hours postoperatively to fasted animals. Ninety minutes after oral gavage, animals 
were sacrificed by CO2 overdose and the contents of stomach, small bowel (divided into 
10 segments of equal length), caecum, and colon (divided in 3 segments of equal length) 
were collected and the amount of FITC in each bowel segment was quantified using a 
spectrofluorimeter (Ascent, Labsystem Inc) at 488 nm. The distribution of the fluorescent 
dextran along the GI tract was determined by calculating the geometric center (GC): Σ 
(percent of total fluorescent signal in each segment x the segment number)/100 for 
quantitative comparison among experimental groups [5]. 
Whole mount preparation and MPO staining  
Twenty four hours after surgery, mice were sacrificed by CO2 overdose. The 
jejunum was quickly excised, and the mesenteric attachment removed. Jejunum segments 
were cut open along the mesentery border, fecal content was washed out in ice-cold 
modified Krebs solution, and segments were fixed with 100% ethanol for 10 minutes. 
Next, the mucosa and submucosa were removed and the remaining full-thickness sheets 
of muscularis externa were stained with Hanker Yates reagent (Sigma-Aldrich) for 10 
minutes [26]. Myeloperoxidase (MPO) positive cells were visualized with a microscope 
(BX 41, Olympus) connected to a camera (XM10, Olympus). The number of MPO-
positive cells was counted by an observer blind to the experimental conditions in 10 
randomly chosen representative low-power magnification fields (acquired with the 10X 
objective, 668.4 µm x 891.2 µm).  
Staining and immunolabeling of mast cells, ICC and intestinal resident 
macrophages 
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Mesenteric windows were carefully preserved and pinned down in a sylgard dish 
and subsequently fixed with 4% paraformaldehyde (Sigma-Aldrich) in PBS at 4°C for 10 
minutes. To stain mast cells, mesenteric windows were incubated with 0.1% of toluidine 
blue (Sigma-Aldrich) for 1 hour and washed in PBS 3 times for 5 minutes. 
Jejunum fragments were fixed with 4% paraformaldehyde and frozen in optimal cutting 
temperature compound (OCT; Neg 50; Thermo Scientific). Jejunum tissues were cut in 
10-μm-thick transversal sections. After blocking for 2 hours at room temperature in 1% 
bovine serum albumin (BSA; Sigma-Aldrich) in PBS, sections were incubated with the 
primary antibodies rat anti Kit (clone 2B8; eBioscience) and rabbit anti Ano1 (Abcam) at 
a concentration of 1:500 in 0.3% (vol/vol) Triton X-100 plus 1% BSA in PBS overnight 
at 4°C. Subsequently, sections were incubated with the appropriate secondary antibodies 
donkey anti-rat conjugated with CY5 (Jackson ImmunoResearch) and donkey anti-rabbit 
conjugated with CY3 (Jackson ImmunoResearch) at a concentration of 1:1000 in 0.3% 
(vol/vol) in Triton X-100 plus 1% BSA in PBS for one hour at room temperature. 
Sections were then counterstained with 4′,6-diamidino-2-phenylindole dilactate (DAPI; 
Invitrogen) to label nuclei. 
Immunolabeling of intestinal resident macrophages was performed as follows.  Jejunum 
muscularis externa whole mount preparation from naïve animals were subjected to two 
hours incubation with 1% bovine serum albumin (BSA, Sigma-Aldrich, St. Louis, MO) at 
room temperature (RT). After blocking, the preparations were incubated overnight with 
the primary antibody rat anti-F4/80 (1:500, Biolegend) in PBS containing 1% BSA and 
0.3% Triton X-100. The next day, the tissues were incubated for 1 hour at room 
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temperature with the secondary antibody donkey anti-rat CY5 conjugated (1.1000, 
Jackson ImmunoResearch).  Immunolabeled tissues were examined with an Olympus 
BX4 epifluorescence microscope (Olympus). Contrast and brightness of the pictures were 
adjusted using Image J software 1.46. 
Quantification of mouse mast cell protease-1 in peritoneal lavage fluid. 
Peritoneal lavage fluid was collected 30 minutes after IM by injection of 1 ml of 
warm sterile saline solution and a gentle massage of the peritoneum for 30 seconds. After 
that, peritoneal lavage fluid was collected and centrifuged at 300g for 5 minutes at 4°C. 
The pellet was discarded and supernatant stored at -80°C until use. Peritoneal levels of 
mouse mast cell protease-1 (mMCP-1) as a measure of mast cell degranulation were 
measured by using a commercially available ELISA kit (eBioscience) following 
manufacturer’s instructions. mMCP-1 levels were normalized to the protein concentration 
in the peritoneal lavage fluid.   
RNA extraction and inflammatory gene expression  
Total RNA was extracted from the muscularis externa of the jejunum 24 hours 
after surgery. To this extent, tissue was homogenized by the TissueLyser II homogenizer 
(Qiagen). RNA extraction was performed using RNeasy Mini Kit (Qiagen) following the 
manufacturer’s instructions. Total RNA was transcribed into complementary DNA 
(cDNA) by qScript cDNA SuperMix (Quanta Biosciences) according to the 
manufacturer’s instructions. Quantitative real-time transcription polymerase chain 
reactions (RT-PCR) were performed with the LightCycler 480 SYBR Green I Master 
(Roche) on the Light Cycler 480, (Roche). Results were quantified using the 2-CT 
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method [27]. The expression levels of the genes of interest were normalized to the 
expression levels of the reference gene rpl32. PCR experiments were performed in 
triplicate. Primer sequences used are listed in table 1. 
Gene Sense Antisense 
Rpl32 5’-AAGCGAAACTGGCGGAAAC-3’ 5’-TAACCGATGTTGGGCATCAG-3’ 
Il6 5’-CCATAGCTACCTGGAGTACATG-3’ 5’-TGGAAATTGGGGTAGGAAGGAC-3’ 
Il1α 5’-GAGAGCCGGGTGACAGTATC-3’ 5’-ACTTCTGCCTGACGAGCTTC-3’ 
Il1β 5’-GACCTTCCAGGATGAGGACA-3’ 5’-TCCATTGAGGTGGAGAGCTT-3’ 
Tnfa 5’-TCTTCTCATTCCTGCTTGTGG-3’ 5’-CACTTGGTGGTTTGCTACGA-3’ 
Cxcl1 5’-GCTGGGATTCACCTCAAGAA-3’ 5’-TCTCCGTTACTTGGGGACAC-3’ 
Ccl2 5’-CACGTGTTGGCTCAGCCAGATGC-3’ 5’-CCTTCTTGGGGTCAGCACAGACC-3’ 
 
Cell isolation from the intestinal muscularis for flow cytometry  
Twenty-four hours after the surgery, muscularis externa from the small intestine 
was isolated and enzymatically digested in MEMα medium (Lonza) containing 100 
µg/ml
 of Penicillin, 100 µg/ml of Streptomycin, 50µM β-mercaptoethanol, 5% FCS, 
5mg/ml protease type I (Sigma-Aldrich), 20mg/ml collagenase type II (Sigma-Aldrich) 
and 5U/ml DNase I for 15min at 37°C. Cell suspensions were pre-incubated with an anti-
FcR antibody (clone
 
24G2; BD Biosciences) and then stained with the following 
antibodies: CD45-APC-eFluor780 (30.F11, eBioscience), CD11b-PE-Cy7 (M1/70, BD 
Biosciences), CD64-Alexa Fluor647 (X54-5/7.1, BD Biosciences), Ly6G-PercPCy5.5 
(IA8, BD Biosciences) and Ly6C-PE (AL-21, BD Biosciences). Stained samples were 
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analyzed on a BD FACSCanto™ flow cytometer (BD Biosciences), and data were 
processed using FlowJo software (version 10.0.6, Tree Star). Cell numbers were 
calculated from flow cytometry frequencies using hemocytometer counts of trypan blue–
excluding cells.  
Cromolyn administration 
Mice received cromolyn (Disodium cromoglycate, Nalcrom®, Italchimici SpA) 
by intraperitoneal injection of 30 mg/kg (in sterile saline solution) every 12 hours. The 
animals received cromolyn at three time points; 13 h and 1h before IM and 11 h after IM 
(n=10). Another group of mice (n=10) received 200 µl of sterile solution (vehicle) at the 
same time points than cromolyn treated group. The researcher performing the surgeries 
was blinded for the type of pharmacological treatment.  
Statistical analysis  
To compare multiple groups, one-way analysis of variance (one-way ANOVA) 
followed by Bonferroni post-hoc test was performed. Probability level of p<0.05 was 
considered statistically significant. Results are shown as mean ± standard error of the 
mean (SEM). Graph Pad Prism V.5.01 software was used to perform statistical analysis 
and generate graphs. 
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Results 
Intestinal manipulation induces peritoneal mast cells degranulation. 
To define if peritoneal mast cells degranulation was induced during IM, we 
performed toluidine staining and quantified mouse mast cell protease-1 (mMCP-1) 
release in the peritoneal cavity of WT and Kit
W-sh/W-sh 
mice. 
Toluidine blue staining showed cells with typical dark-blue or purple cytoplasmic 
granules resembling mast cells in the mesenteric window of WT mice (Figure 1A). As 
expected, no mast cells were found in the mesenteric windows from Kit
W-sh/W-sh
 mice 
(Figure 1A). IM induced typical signs of degranulation in WT mice, as visualised in 
Figure 1A by the appearance of dark-blue (toluidine blue-positive) structures released 
from and in the surrounding of a mast cell in the mesenteric window. In line, in the 
peritoneal lavage fluid of WT mice significant amount of mMCP-1 was detected already 
30 minutes after IM (Lap; 0.036±0.0011 vs Lap + IM; 0.990±0.483 ng/ml; Figure 1B).  
As control, IM in the mast cell-deficient Kit
W-sh/W-sh
 mutant mice did not lead to increase 
in peritoneal levels of mMCP-1 (Lap; 0.044±0.0013 vs Lap + IM; 0.039±0.009 ng/ml; 
Figure 1B).  
       As previously reported, IM in WT mice resulted in a significant delay in 
gastrointestinal transit (as measured by a reduction in the geometrical center values, GC) 
compared to laparotomy (Figure 1C). In line with our previous observations IM led to 
recruitment of MPO-positive cells to the muscularis externa (Figure 1D). To define the 
role of mast cells in the pathogenesis of POI, IM was performed also in Kit
W-sh/W-sh 
mutant 
mice. As shown in figure 1C, gut transit was already significantly delayed in Kit
W-sh/W-sh 
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mutants undergoing laparotomy compared to control WT mice and IM did not worsen 
gastrointestinal transit in Kit
W-sh/W-sh
 mice
 
when compared to their laparotomy controls. 
Interestingly, IM in Kit
W-sh/W-sh
  mice resulted however in recruitment of MPO-positive 
cells to the muscularis externa with the same extent as in WT mice (WT; 143±18 number 
of cells per field vs Kit
W-sh/W-sh
  95±20 number of cells per field, ns, Figure 1D). Since IM 
induced recruitment of MPO-positive cells even in the absence of mast cells (Kit
W-sh/W-sh
) 
we analyzed the inflammatory response in the muscularis externa by assessing mRNA 
cytokines expression and the recruited of immune cells. In line with the number of MPO-
positive cells IM significantly increased cytokines mRNA expression (Il6, Il1a, Il1b, 
Tnfa, Cxcl1 and Ccl2; Figure 2) in the muscularis externa of Kit
W-sh/W-sh
 mice when 
compared to laparotomy mice.  
Intestinal manipulation-induced recruitment of immune cells to the muscular is a typical 
event in POI. Therefore, we determined by flow cytometry the recruitment of immune 
cells in WT and Kit
W-sh/W-sh
 mutant mice after laparotomy or laparotomy plus intestinal 
manipulation. As shown in figure 3, IM induced a significant increase in CD45-positive 
immune cells, monocytes and neutrophils in the small intestine muscularis both in WT 
and Kit
W-sh/W-sh
 mutant mice. Interestingly, no difference in the percentage and in the 
absolute number of monocytes and neutrophils were detected between WT and Kit
W-sh/W-sh
 
mutant mice (Figure 3C-D).  
Taking into account that muscularis externa resident macrophages are suggested to be 
key players in the development of postoperative ileus in rodents and humans we 
performed F4/80 immunolabeling in jejunum whole mount muscularis preparations from 
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WT and Kit
W-sh/W-sh 
mutant mice. As shown in figure S1 distribution and number of F4/80-
positive resident macrophages are comparable in both WT and Kit
W-sh/W-sh 
mutant mice. 
Kit
W-sh/W-sh
 mice lack cells of Cajal (ICC) and have altered gastrointestinal transit. 
Taking into account that Kit signaling is essential for the development of ICC and 
that gut motility is impaired in Kit
W-sh/W-sh 
mutant mice we performed immunolabelling of 
the ICC network in WT and Kit
W-sh/W-sh
 mice. As previously reported in the jejunum of 
WT mice, anti-Kit antibody labelled ICC located at the level of the deep muscular and 
myenteric plexus regions of the muscularis externa (Figure 4A), as well as mast cells 
(white arrows figure 4A, panel right). However, no Kit positive cells, mast cells or ICC, 
were found in the muscularis externa from Kit
W-sh/W-sh 
mutant mice (Figure 4B). To search 
for the presence of ICC independently of Kit staining in Kit
W-sh/W-sh
 mice, we used the 
recently described ICC marker Anoctamin-1 (Ano1) [28]. In the jejunum of WT mice, 
Ano1 co-stained with Kit specifically the networks of ICCs located at the deep muscular 
and at the myenteric plexus regions (Figure 4A). By contrast, in the small bowel of Kit
W-
sh/W-sh 
mutant mice, Ano1 immunoreactivity was found exclusively at the level of the deep 
muscular plexus region (Figure 4B), where only few cells with typical ICC morphology 
were found (Figure 4B). Our results confirm a malformation of the ICC networks in the 
Kit
W-sh/W-sh 
mutant mice (Figure 4A and B). This alteration in the number and distribution 
of the ICC in the Kit
W-sh/W-sh 
mutant mice was associated with significant gut dysmotility 
found in both naïve mice and mice subjected to laparotomy (Figure 4C and D).  
Therefore, we conclude that Kit
W-sh/W-sh 
is not an adequate mouse model to study the role 
of mast cells in POI. 
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Mast cell-deficient Cpa3
Cre/+
 mice had normal ICC network and regular 
gastrointestinal transit. 
Considering that naïve untreated Kit
W-sh/W-sh 
mice have already severe alteration of 
the gut motility we decided to utilize in our study a newly described mast cell–deficient 
mouse strain Cpa3
Cre/+
 with non-perturbed Kit functions [18]. Using toluidine staining 
and Kit immunolabelling we observed a lack of mast cells both in the peritoneal cavity 
(Figure 5A) and in the intestinal mucosa (Figure 5B). Interestingly, and contrast to 
previously described Kit mast cell-deficient mice, Kit labeling of the muscularis externa 
revealed the presence of a normal network of ICCs in the deep muscular plexus and in the 
myenteric regions in Cpa3
Cre/+ 
(Figure 5D), with no relievable differences compared to 
littermate control Cpa3
+/+ 
mice (Figure 5C). To assess whether the presence of normal 
ICCs in the absence of mast cells is associated with normal gut motility, we performed 
gastrointestinal transit analyses in Cpa3
Cre/+
 mice without surgery or only after 
laparotomy.  As depicted in figure 5E and F, Cpa3
Cre/+
 mice have normal GI transit with 
no significant difference when compared to Cpa3
+/+
 littermate or
 
to
 
wild type C57BL/6 
mice. In addition, as shown in figure S1 the distribution and number of F4/80-positive 
muscularis externa resident macrophages are comparable in both Cpa3
Cre/+ 
and littermate 
control mice. 
Mast cell-deficient Cpa3
Cre/+
 mice develop postoperative ileus and surgery-induced 
muscularis externa inflammation. 
To define if the presence of mast cells has an influence on the development of 
POI we performed intestinal manipulation in mast cell-deficient Cpa3
Cre/+
 mice and in 
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Cpa3
+/+
 littermate controls. Despite the absence of mesenteric as well as intestinal mast 
cells (Figure 5A and B), IM in Cpa3
Cre/+
 mice induced a delay in GI transit as shown by a 
reduction in GC value (Cpa3
Cre/+
 lap; GC: 10.2±0.2 vs Cpa3
Cre/+
 IM, GC: 4.1±0.3). The 
extent of this delay was indistinguishable to littermate control Cpa3
+/+
 mice (Cpa3
+/+
 lap; 
GC: 10.2±0.3 vs Cpa3
+/+
 IM, GC: 4.2±0.6) (Figure 6A). Next, peritoneal levels of 
mMCP-1 were assessed in Cpa3
Cre/+
 and Cpa3
+/+
 mice 30 minutes after IM. Consistent 
with their mast cell deficiency, IM did not increase peritoneal mMCP-1 in Cpa3
Cre/+
 mice 
(Lap; 0.074±0.0023 vs Lap + IM; 0.036±0.008 ng/ml; Figure 6B) while Cpa3
+/+
 had a 
significant increase of this protein in IM versus laparotomy (Lap; 0.076±0.0015 vs Lap + 
IM; 1.251±0.273 ng/ml; Figure 6B). Intestinal manipulation in mast cell-deficient 
Cpa3
Cre/+
 mice also led to inflammatory response in the muscularis externa based on 
influx of MPO-positive cells (Cpa3
Cre/+
; 94±14 number of cells per field; Figure 6C) with 
no significant difference to littermate controls (Cpa3
+/+
; 113±11 number of cells per 
field; Figure 6C). A normal inflammatory response to IM in the absence of mast cells was 
also evident by the fact that IM-induced mRNA levels for a range of inflammatory 
cytokines (Il6, Il1a, Il1b, Tnfa, Cxcl1 and Ccl2) in the muscularis externa were 
comparable in Cpa3
Cre/+
 mice and littermate controls (Figure 7).  
As previously reported intestinal manipulation leads to the recruitment of neutrophils and 
monocytes in the muscularis externa. To determine if lack of mast cells would affect this 
process, we assessed by flow cytometry the immune cells infiltrating the small bowel 
muscularis of Cpa3
Cre/+
 and Cpa3
+/+
 mice 24 hours after laparotomy or laparotomy plus 
intestinal manipulation. As evident in figure 8, no difference in the percentage and in the 
absolute number of CD45-positive immune cells, monocytes and neutrophils were found 
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between Cpa3
Cre/+
 and littermate control Cpa3
+/+
 mice subjected to laparotomy or 
laparotomy plus intestinal manipulation.  
Cromolyn treatment inhibits mast cell degranulation but does not prevent POI 
The use of mast cell stabilizers is an additional strategy to address roles of mast 
cells under pathological conditions. Thus, we tested the ability of the typical mast cells 
stabilizer, cromolyn, to influence the response to IM [29]. Cromolyn significantly 
inhibited the release of mMCP-1 in the peritoneal cavity evoked by IM (Supplementary 
figure 2A). Nevertheless, mice treated with cromolyn still developed delayed GI transit 
following IM, similar to the vehicle treated mice (Supplementary figure 2B).   
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Discussion 
Recent evidence shows that postoperative ileus is mediated by infiltration of 
leukocytes in the intestinal muscle layer in response to surgical handling of the gut [8–
10]. Activation of resident macrophages and mast cells has been proposed to be involved 
in this inflammatory response. However, we here demonstrate, using the mast cell-
deficient Cpa3
Cre/+
 mouse strain, that mast cell do not have a crucial role in the 
pathogenesis of POI. In the current experiments we used a new mouse strain devoid of 
both mucosal and connective tissue subtypes of mast cells [18]. In this mouse strain, Cre 
recombinase is driven by the Cpa3 locus which is expressed in mast cells from their 
progenitor stage onwards. Cpa3
Cre/+
 mice have been used previously to re-address the 
proposed roles of mast cells in autoimmunity, refuting an involvement of mast cells in the 
tested models of antibody and T cell-mediated autoimmunity [18].  
Considering that Kit signaling is crucial for the development of normal ICC networks and 
intestinal motility, an important read-out in our POI model, it was critical to use mice 
with normal ICC. Indeed, Cpa3
Cre/+
 mice, in contrast to previously used mast cell-
deficient strains, have intact Kit signaling. Consequently, we found normal ICC networks 
and regular intestinal transit time in Cpa3
Cre/+
 mice (Figure 5). Moreover, the immune 
system is not compromised (with the exception of a lower number of basophil) in 
Cpa3
Cre/+
 mice, whereas other Kit mutant mast cell-deficient strains have deficiencies in 
several immune cell subtypes or their functions. Clearly, although no mast cells could be 
demonstrated based on histology and mast cell mediator release following surgery, 
Cpa3
Cre/+ 
developed IM-induced intestinal inflammation and delay of gastrointestinal 
transit, the two hallmark features of POI, to the same extent as Cpa3
+/+ 
littermate mice 
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(Figure 6). The fact that Cpa3
Cre/+ 
mice
 
developed full POI strongly argues against mast 
cells as crucial player in the development of POI.  
 In contrast to our new data, a role for mast cells in POI had been invoked based on 
previous findings. First, mast cell products such as tryptase were released in the 
peritoneal cavity after intestinal manipulation both in rodents and human [9,10].  
However, in addition to mast cells other immune cells such as basophils and neutrophils 
may also be a source of tryptase [30]. Second, the mast cell secretagogue compound 
48/80 (C48/80) was used to provoke mast cell activation leading to muscularis 
inflammation, as indicated by an increase in MPO-positive cell infiltration. However, an 
effect on gut motility was not assessed under these conditions [9]. Moreover, C48/80 has 
other non-specific effects amongst which inducing oxidative stress [31],vasodilatation 
[32], and it acts on other immune and non-immune cells including basophils [33], 
neurons [34,35] and fibroblasts [36]. In line with these findings, the interpretation of the 
data acquired using the mast cells stabilizers such as ketotifen or doxantrazole should be 
used with caution, considering their broad anti-inflammatory effect mainly independent 
of mast cells [37–40]. In previous studies reconstitution experiments with wild type mast 
cells were used to restore the phenotype which suggested a role for mast cells in POI. 
Accumulating evidence, however, questions this approach. It is now clear that although 
bone marrow-derived mast cells (BMMCs) can adopt the phenotype of normal tissue 
mast cells after in vivo transfer, numbers, distribution, and functional responses of 
reconstituted mast cells may not always be physiological [19]. Indeed, several reports 
using BMMC reconstitution showed a reversal of the phenotype in Kit mutant mice but 
this has not been confirmed when tested independently in mast cell-deficient mice wild 
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type for Kit. Hence, mast cell reconstitution of Kit mutants does not necessarily reflect 
mast cell functions in the presence of intact Kit signaling, and may lead to 
misinterpretation of experimental data and incorrect conclusions [19]. Collectively, none 
of these previous experiments directly and conclusively proved mast cells to be involved 
in intestinal pathology. 
In addition to these pharmacological studies, the role of mast cells in POI has been 
traditionally investigated using mice that are mast cell-deficient due to impaired Kit 
signaling, such as Kit
W/Wv
 and Kit
W-sh/W-sh
 mice. However, these mouse strains have 
pleiotropic phenotypes affecting multiple cell types which comprise normal tissue 
functions inside and outside of the immune system, as reviewed in [19]. For example, 
Kit
W/W-v
 mice suffer from anemia and neutropenia, and lack subsets of intra-epithelial 
lymphocytes. A strain more recently used in mast cell research, Kit
W-sh/W-sh 
mice, displays 
a milder spectrum of abnormalities, but is also affected by immunological abnormalities 
such as splenomegaly, accumulation of granulocytic myeloid-derived suppressor cells 
(G-MDSC) [12], expanded myeloid and megakaryocyte populations, neutrophilia and 
thrombocytosis [13] [14]. These defects in Kit
W-sh/W-sh 
mice may have contributed to the 
reported lower inflammatory response, and the reduced number of MPO-positive cells in 
the muscularis externa after intestinal manipulation [9]. However, here we provide 
evidence that in Kit
W-sh/W-sh
 intestinal manipulation induced muscularis externa 
inflammation (increase in cytokine expression and recruitment of monocytes and 
neutrophils) even in the absence of mast cells (Figure 1 to 3).   
Given that ICC networks in the intestinal wall fail to develop normally in Kit mutant 
mice [15–17], it is not surprising to observe a significant delay in the gastrointestinal 
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transit in naïve Kit
W-sh/W-sh 
mice (Figure 4). As gastrointestinal transit is one of the major 
parameters of POI, the ICC defect should exclude Kit-based mouse models for studying 
the pathogenesis of ileus. In contrast to Kit mutants, Cpa3
Cre/+
 mice have an intact ICC 
network and normal intestinal motility (Figure 5) and their immune system is not 
compromised [18]. Notably, mast cell-deficient Cpa3
Cre/+ 
mice developed IM-induced 
intestinal inflammation and delay of gastrointestinal transit, the two hallmarks of POI, to 
the same extent as their mast cell-proficient littermates, indicating that mast cells are not 
involved in POI (Figure 6 to 8). In support of this conclusion, cromolyn treatment (30 
mg/kg; a dose which has been proved to stabilize mast cells in vivo [29]) was ineffective 
in preventing POI (Supplementary figure 2).  
In conclusion, our study demonstrates that mast cells, at least in mice, do not play a 
crucial role in the development of POI, and provide a further example of experimental 
discrepancies comparing mast cell- and Kit double-deficient mutants versus mast cell-
deficient mice without defects in Kit signaling as discussed in [19]. These findings should 
be definitively taken into account when designing new therapeutic strategies to shorten 
POI.  
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Figures legend 
Figure 1. Intestinal manipulation in Kit
W-sh/W-sh
 mice induces intestinal inflammation 
in the absence of mast cells. WT and Kit
W-sh/W-sh 
mice were subjected to laparotomy 
alone (Lap) or to laparotomy plus intestinal manipulation (Lap + IM). (A) Mesenteric 
windows from WT and Kit
W-sh/W-sh 
mutant mice were collected 30 min after surgeries and 
stained with 0.1% toluidine blue. Scale bar 50 µm. (B) 30 minutes after surgery the levels 
of mouse mast cell protease-1 (mMCP-1) was determined by ELISA in the peritoneal 
lavage fluid of WT and Kit
W-sh/W-sh
. (C) Geometric center (GC) values representing the 
dextran distribution through the GI tract 24 hours after surgery. (D) Infiltration of MPO-
positive cells in the muscularis externa 24 hours after surgery. Data expressed as mean ± 
SEM. * P < 0.01 (one-way ANOVA followed by Bonferroni post-hoc test). Dots 
represent individual mice. 
Figure 2. Intestinal manipulation in Kit
W-sh/W-sh
 mice induces cytokines expression in 
the absence of mast cells WT and Kit
W-sh/W-sh 
mice were subjected to laparotomy alone 
(Lap) or to laparotomy plus IM (Lap + IM). Twenty four hours after surgery muscularis 
externa was collected and cytokines mRNA expression assessed by qPCR.  Il6 (A), Il1a 
(B), Il1b (C), Tnfa (D), Cxcl1 (E)  and Ccl2 (F) mRNA expression was evaluated in the 
jejunum muscularis externa after 24 h. Data expressed as mean ± SEM. * P < 0.05, ** P 
< 0.01 or *** P < 0.001 (one-way ANOVA followed by Bonferroni post-hoc test). Dots 
represent individual mice. 
Figure 3. Intestinal manipulation in Kit
W-sh/W-sh
 mice induces recruitment of immune 
cells in the muscularis externa in the absence of mast cells. WT and Kit
W-sh/W-sh 
mice 
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were subjected to laparotomy alone (Lap) or to laparotomy plus intestinal manipulation 
(Lap + IM) and immune cell recruitment in the muscle layer of the small intestine was 
assessed by flow cytometry. Typical dot plot showing different population of CD45-
positive cells in WT and Kit
W-sh/W-sh 
mice after (A)  laparotomy or (B) laparotomy plus 
intestinal manipulation. Absolute number of CD45 positive immune cells (C), monocytes 
(D) and neutrophils (E) were calculated from flow cytometry frequencies using viable 
cell counts. Data expressed as mean ± SEM. ** P < 0.01 or *** P < 0.001 (one-way 
ANOVA followed by Bonferroni post-hoc test). Dots represent individual mice. 
 
Figure 4. Deficient ICC network and intestinal dysmotility in Kit
W-sh/W-sh 
mice.   ICC 
network in the intestinal wall and GI transit were assessed in WT and Kit
W-sh/W-sh 
mice.  
Jejunum sections from naïve WT mice (A) or Kit
W-sh/W-sh 
mice (B) were immunolabeled 
with anti-Kit (red) and anti-Ano1 (green) antibodies. Sections were counterstained with 
DAPI (blue) to identify nuclei. White arrows are pointing Kit-positive and Ano1-negative 
mast cells in the jejunum from a WT mouse. DMP, deep muscular plexus; MYP, 
myenteric plexus; CM, circular muscle layer and LM, longitudinal muscle layer. Scale 
bar 50 µm.  90 min after oral gavage with dextran-FITC naïve (C) or animals subjected to 
laparotomy (D) WT and Kit
W-sh/W-sh 
were sacrificed and dextran-FITC distribution through 
the GI tract was determined as indicative of GI transit.  Data expressed as mean. *** P < 
0.001 (two-way ANOVA).  
Figure 5. Cpa3
Cre/+
 mice lack mesenteric and mucosal mast cells but have normal 
ICC network and gut motility.  Naïve Cpa3
Cre/+
 and littermates control Cpa3
+/+
 mice 
were used to analyze intestinal mast cells, ICCs and GI transit. (A) Mesenteric windows 
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from Cpa3
+/+
 and Cpa3
Cre/+
 mice were stained with 0.1% toluidine blue. Scale bar 50 
µm. (B) Jejunum mucosa sections from naïve Cpa3
+/+
 and Cpa3
Cre/+
 mice were 
immunolabeled with Kit antibody (red) and counterstained with DAPI (blue). Scale bar 
25 µm. White arrows are pointing to mast cells in Cpa3
+/+
 mice. To reveal ICCs, jejunum 
sections from Cpa3
+/+ 
(C) and Cpa3
Cre/+
 (D) mice were immunolabeled with Kit (red) 
and counterstained with DAPI (blue). DMP, deep muscular plexus; MYP, myenteric 
plexus; CM, circular muscle layer and LM, longitudinal muscle layer. Scale bar 50 µm. 
GI transit was evaluated in naïve (E) or animal subjected to laparotomy (F) 
C57BL/6JOlaHsd, Cpa3
+/+
 and Cpa3
Cre/+
 mice by assessing dextran-FITC distribution 
through the GI tract during 90 min after oral gavage. Data are expressed as means. No 
significant differences were found between the groups of animals (two-way ANOVA). 
Figure 6. Intestinal manipulation induces postoperative ileus and recruitment of 
MPO-positive cells in the muscularis externa independently of mast cells. Cpa3
Cre/+
 
and littermates control Cpa3
+/+
 mice were subjected to laparotomy alone (lap) or to 
laparotomy plus IM (lap + IM). GI transit was evaluated 24 h after surgery by assessing 
dextran-FITC distribution through the gastrointestinal tract 90 min after oral gavage. (A) 
Graph represents GC values. (B) Peritoneal levels of mMCP-1 were determined by 
ELISA in Cpa3
+/+
 and Cpa3
Cre/+
 mice.  (C) Representative images of MPO-positive cells 
in the muscularis externa 24 h after surgery in Cpa3
Cre/+
 and littermates control Cpa3
+/+
 
mice.  (D) Histogram represents numbers of MPO-positive cells in the muscularis externa 
24 h after surgery in Cpa3
Cre/+
 and littermates control Cpa3
+/+
.  Data expressed as mean 
± SEM. * P < 0.01 (one-way ANOVA followed by Bonferroni post-hoc test). Dots 
represent individual mice. 
P. Gomez-Pinilla et al. 
 
Mast cells are not involved in the induction of postoperative ileus     27 
Figure 7. Intestinal manipulation induces muscularis externa inflammation 
independently of mast cells. Cpa3
Cre/+
 and littermate control Cpa3
+/+
 mice were 
subjected to laparotomy alone (Lap) or to laparotomy plus IM (Lap + IM). Twenty four 
hours after surgery muscularis externa was collected and cytokines mRNA expression 
assessed by qPCR.  Il6 (A), Il1a (B), Il1b (C), Tnfa (D), Cxcl1 (E)  and Ccl2 (F) mRNA 
expression was evaluated in the jejunum muscularis externa after 24 h. Data expressed as 
mean ± SEM. * P < 0.01 (one-way ANOVA followed by Bonferroni post-hoc test). Dots 
represent individual mice. 
Figure 8. Intestinal manipulation induces recruitment of immune cells in the 
muscularis externa in the absence of mast cells. Cpa3
Cre/+
 and littermate control 
Cpa3
+/+
 mice were subjected to laparotomy alone (Lap) or to laparotomy plus intestinal 
manipulation (Lap + IM) and immune cells recruitment in the muscle layer of the small 
intestine was assessed by flow cytometry. Typical dot plot showing different population 
of CD45-positive cells in Cpa3
Cre/+
 and littermate control Cpa3
+/+
 mice after (A)  
laparotomy or (B) laparotomy plus intestinal manipulation. Absolute number of CD45 
positive immune cells (C), monocytes (D) and neutrophils (E) were calculated from flow 
cytometry frequencies using viable cell counts. Data expressed as mean ± SEM. *** P < 
0.001 (one-way ANOVA followed by Bonferroni post-hoc test). Dots represent 
individual mice. 
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Supplementary figure 1. Cpa3Cre/+ mice lack mesenteric and mucosal mast cells but have 
normal ICC network and gut motility.  Naïve WT, KitW-sh/W-sh or Cpa3Cre/+ and littermates 
control Cpa3+/+ mice were used to analyze the network of resident muscularis externa 
macrophages. Muscularis externa isolated from the jejunum of WT or KitW-sh/W-sh mice (A) or 
Cpa3Cre/+ and littermates control Cpa3+/+ mice (B) was stained using an anti-F4/80 antibody. 
Scale bare 50µm. Typical network of F4/80 positive macrophages (red) was detected in all the 
mouse strains analyzed. 
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Supplementary figure 2. Cromolyn treatment inhibits mast cell degranulation during 
intestinal manipulation but does not prevent induction of POI. WT mice treated with 30 
mg/Kg of cromolyn or vehicle were subjected to laparotomy alone (Lap) or to laparotomy 
plus IM (Lap + IM).  (A) Peritoneal levels of mMCP-1 were determined by ELISA. (B) GI 
transit was evaluated 24 h after IM and GC values calculated. Data are expressed as mean ± 
SEM. * P < 0.05 (one-way ANOVA followed by Bonferroni post-hoc test). Dots represent 
individual mice. 
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